For the Inventor, By the Inventor

Enter assignee name

Eschborn, Germany

Innoplexus Ag

USPTO Granted Patents = 73

% Expired Patents = 17.8

EPO Patents = 2

Trademarks = 7

Forward Citations = 602

Loading Chart...

Loading Chart...

73 inventors (with patents filed for the assignee):

Vatsal Agarwal (29 out of 29 patents)

Gaurav Tripathi (23 out of 23 patents)

Abhijit Keskar (22 out of 22 patents)

4. Gunjan Bhardwaj (11 out of 11 patents)

5. Dileep Dharma (10 out of 10 patents)

6. Akshesh Doshi (5 out of 5 patents)

7. Tapashi Mandal (5 out of 5 patents)

8. Om Sharma (5 out of 5 patents)

9. Tanay Gahlot (4 out of 4 patents)

10. Nikhil Vinod Fulzele (4 out of 4 patents)

11. Pawan Kumar (4 out of 4 patents)

12. Shubhojit Mallick (3 out of 3 patents)

13. Sandeep Singh (3 out of 3 patents)

14. Sunil Patel (3 out of 3 patents)

15. Sudhanshu Shekhar (3 out of 3 patents)

Core Competencies:

Blockchain

Drug Discovery

Data Management

Entity Records

Machine Learning

Search Database

Document Management

Contextual Information

Interoperability

Clinical Trials

Secure Transactions

Ontology Generation

73 patents: Sort by Forward Citations

1. 12488867 - System for prediction of the drug target landscape for therapeutic use and a method thereof (2025-12-02),

2. 12462325 - Method and system for converting a protein data bank file into a grayscale image array (2025-11-04),

3. 12393560 - Method and system for performance evaluation of cluster algorithms (2025-08-19),

4. 12013811 - System and method of workload management for distributing workload over SIMD based parallel processing architecture (2024-06-18),

5. 11995644 - System and method for managing transactional interoperability amongst blockchains (2024-05-28),

6. 11954111 - System and method for executing service request (2024-04-09),

7. 11943229 - System and method of managing access to remote digital platforms (2024-03-26),

8. 11908551 - System and method for identifying potential targets for pharmaceutical compound (2024-02-20),

9. 11775665 - System and method for executing access transactions of documents related to drug discovery (2023-10-03),

10. 11669555 - System and method of creating index (2023-06-06),

11. 11636119 - System and method for efficient management of a search database for retrieving context-based information (2023-04-25),

12. 11586612 - System and method for intermediary-less database management (2023-02-21),

13. 11550825 - System and method for identifying at least one association of entity (2023-01-10),

14. 11544304 - System and method for parsing user query (2023-01-03),

15. 11526561 - System and method for determining temporal citation count (2022-12-13),

Company Overview

Innoplexus Ag, based in Eschborn, Germany, specializes in blockchain analytics with a focus on enhancing drug discovery processes. The company leverages advanced technologies such as machine learning and data management to provide contextual information and streamline entity records. By integrating blockchain solutions, Innoplexus aims to improve the transparency and efficiency of data handling in the pharmaceutical sector, facilitating better decision-making and innovation in drug development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

73 Patents

#1 in Eschborn

#786 in Germany

#10,263 in the World

Eschborn, Germany

Innoplexus Ag

Forward Citations = 602

73 inventors:

Vatsal Agarwal (29 out of 29 patents)

Gaurav Tripathi (23 out of 23 patents)

Abhijit Keskar (22 out of 22 patents)

4. Gunjan Bhardwaj (11 out of 11 patents)

5. Dileep Dharma (10 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Innoplexus Ag. Retrieved from https://idiyas.com/company/innoplexus-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…